| Stem cell therapy for neurological disorders M Alessandrini, O Preynat-Seauve, K De Bruin, MS Pepper South African Medical Journal 109 (8 Supplement 1), S71-S78, 2019 | 132 | 2019 |
| Factors influencing the umbilical cord blood stem cell industry: an evolving treatment landscape C Dessels, M Alessandrini, MS Pepper Stem cells translational medicine 7 (9), 643-650, 2018 | 89 | 2018 |
| University entrepreneurship in South Africa: Developments in technology transfer practices M Alessandrini, K Klose, MS Pepper Innovation 15 (2), 205-214, 2013 | 58 | 2013 |
| Cytochrome P450 pharmacogenetics in African populations M Alessandrini, S Asfaha, TM Dodgen, L Warnich, MS Pepper Drug metabolism reviews 45 (2), 253-275, 2013 | 57 | 2013 |
| Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant S Ilmjärv, F Abdul, S Acosta-Gutiérrez, C Estarellas, I Galdadas, ... Scientific reports 11 (1), 13705, 2021 | 55 | 2021 |
| Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine A Čolić, M Alessandrini, MS Pepper Drug metabolism reviews 47 (2), 111-123, 2015 | 38 | 2015 |
| Processing of glasses with engineered stress profiles VM Sglavo, A Prezzi, M Alessandrini Journal of non-crystalline solids 344 (1-2), 73-78, 2004 | 35 | 2004 |
| Pharmacogenomics and global precision medicine in the context of adverse drug reactions: Top 10 opportunities and challenges for the next decade M Alessandrini, M Chaudhry, TM Dodgen, MS Pepper Omics: a journal of integrative biology 20 (10), 593-603, 2016 | 34 | 2016 |
| Injectable, scalable 3D tissue-engineered model of marrow hematopoiesis DN Tavakol, J Tratwal, F Bonini, M Genta, V Campos, P Burch, S Hoehnel, ... Biomaterials 232, 119665, 2020 | 33 | 2020 |
| Altered humoral immune responses and IgG subtypes in NOX2-deficient mice and patients: a key role for NOX2 in antigen-presenting cells J Cachat, C Deffert, M Alessandrini, P Roux-Lombard, A Le Gouellec, ... Frontiers in immunology 9, 1555, 2018 | 23 | 2018 |
| Impact of CYP2D6 Genotype on Amitriptyline Efficacy for the Treatment of Diabetic Peripheral Neuropathy: A Pilot Study M Chaudhry, M Alessandrini, J Rademan, TM Dodgen, FE Steffens, ... Pharmacogenomics 18 (5), 433-443, 2017 | 20 | 2017 |
| Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort TM Dodgen, CDJ Labuschagne, A Van Schalkwyk, FE Steffens, ... The pharmacogenomics journal 16 (6), 566-572, 2016 | 15 | 2016 |
| Priority pharmacogenetics for the African continent: focus on CYP450 M Alessandrini, MS Pepper Pharmacogenomics 15 (3), 385-400, 2014 | 15 | 2014 |
| Epidemiologically most successful SARS-CoV-2 variant: concurrent mutations in RNA-dependent RNA polymerase and spike protein S Ilmjärv, F Abdul, S Acosta-Gutiérrez, C Estarellas, I Galdadas, ... MedRxiv, 2020.08. 23.20180281, 2020 | 14 | 2020 |
| Optimizing synthetic miRNA minigene architecture for efficient miRNA hairpin concatenation and multi-target gene knockdown F Rousset, P Salmon, S Bredl, O Cherpin, M Coelho, R Myburgh, ... Molecular Therapy-Nucleic Acids 14, 351-363, 2019 | 14 | 2019 |
| Equitable access to cell and gene therapies in South Africa: opportunities and hurdles CL Hendricks, M Alessandrini, MS Pepper Gene Therapy 30 (1), 180-186, 2023 | 13 | 2023 |
| Cell and gene therapies at the forefront of innovative medical care: Implications for South Africa MS Pepper, M Alessandrini, A Pope, W Van Staden, RJ Green South African Medical Journal 109 (1), 20-22, 2019 | 12 | 2019 |
| Cystic fibrosis in South Africa: a changing diagnostic paradigm J Van Rensburg, M Alessandrini, C Stewart, MS Pepper South African Medical Journal 108 (8), 624-628, 2018 | 11 | 2018 |
| Pharmacogenomics for infectious diseases in sub-Saharan Africa: successes and opportunities M Chaudhry, M Alessandrini, MS Pepper Applied & Translational Genomics 9, 3, 2016 | 11 | 2016 |
| Allelic variants of the Melanocortin 4 receptor (MC4R) gene in a South African study group M Logan, MT Van der Merwe, TM Dodgen, R Myburgh, A Eloff, ... Molecular genetics & genomic medicine 4 (1), 68-76, 2016 | 11 | 2016 |
